scholarly article | Q13442814 |
P2093 | author name string | J R Perfect | |
D L Granger | |||
J B Hibbs | |||
D T Durack | |||
P2860 | cites work | L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells | Q68981146 |
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing | Q70428568 | ||
Nitrate synthesis in the germfree and conventional rat | Q70542428 | ||
Effects of activated macrophages on tumor target cells in discrete phases of the cell cycle | Q71393808 | ||
Defensins. Natural peptide antibiotics of human neutrophils | Q24563852 | ||
An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans | Q33904365 | ||
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible | Q34539273 | ||
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide | Q34547882 | ||
Chronic cryptococcal meningitis: a new experimental model in rabbits | Q35863351 | ||
Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells | Q36209398 | ||
Increased superoxide anion production by immunologically activated and chemically elicited macrophages | Q36341599 | ||
Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates | Q36342907 | ||
Subcellular location and properties of bactericidal factors from human neutrophils | Q36353129 | ||
Nitrate biosynthesis in man | Q36384530 | ||
Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration | Q37020243 | ||
Mammalian nitrate biosynthesis: incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment | Q37343268 | ||
Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide | Q37555750 | ||
Magnitude of the host nutritional responses to infection | Q39864510 | ||
A Reevaluation of the Roles of the O2-Dependent and O2-Independent Microbicidal Systems of Phagocytes | Q40161623 | ||
Pigment production by Cryptococcus neoformans from para- and ortho-Diphenols: effect of the nitrogen source | Q40238982 | ||
Leukocyte endogenous mediator alters protein dynamics in rats | Q40834891 | ||
Oxidation of ammonia and hydroxylamine to nitrate in the rat and in vitro | Q41592652 | ||
Associations of ninhydrin-reacting compounds in the seeds of 49 species of Lathyrus | Q41960747 | ||
Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells | Q43885432 | ||
Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages | Q46261881 | ||
Cytostatic effects of activated macrophages on tumor target cells: inhibition of cytotoxic action of ARA-C. | Q46692628 | ||
Macrophage-mediated fungistasis: requirement for a macromolecular component in serum. | Q50908532 | ||
Activated oxygen and mammalian nitrate biosynthesis. | Q53551041 | ||
Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. | Q54012804 | ||
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. | Q55057549 | ||
Activated macrophages kill tumour cells by releasing arginase | Q59065414 | ||
Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity | Q68857500 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
P304 | page(s) | 1129-1136 | |
P577 | publication date | 1988-04-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages | |
P478 | volume | 81 |
Q34470526 | 8-nitroguanosine formation in viral pneumonia and its implication for pathogenesis |
Q64082805 | A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans |
Q42848232 | A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation |
Q36513491 | ALL2, a Homologue of ALL1, Has a Distinct Role in Regulating pH Homeostasis in the Pathogen Cryptococcus neoformans. |
Q36356195 | Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide |
Q35785931 | Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. |
Q34153407 | Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. |
Q36356019 | An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro |
Q71730956 | Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum |
Q42463616 | Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers |
Q73026484 | Assessment of bovine mononuclear phagocytes and neutrophils for induced L-arginine-dependent nitric oxide production |
Q39714048 | Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms |
Q38003366 | Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"? |
Q37126054 | Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action |
Q43145768 | Biocompatibility of acellular dermal matrix graft evaluated in culture of murine macrophages |
Q38956742 | CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans |
Q50045987 | Caloric restriction increases free radicals and inducible nitric oxide synthase expression in mice infected with Salmonella Typhimurium |
Q37345802 | Candida albicans-macrophage interactions: genomic and proteomic insights |
Q35780552 | Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs. |
Q39821669 | Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells |
Q33946649 | Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection |
Q38229538 | Current concepts in cryptococcosis |
Q40840535 | Cytokines and nitric oxide as effector molecules against parasitic infections |
Q77164099 | Cytokines as therapy for opportunistic fungal infections |
Q35042527 | Cytotoxicity associated with induction of nitric oxide synthase in rat duodenal epithelial cells in vivo by lipopolysaccharide of Helicobacter pylori: inhibition by superoxide dismutase |
Q77907848 | Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues |
Q39827212 | Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide |
Q33922362 | Dietary vitamin E and T cell-mediated function in the elderly: effectiveness and mechanism of action. |
Q43636335 | Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide |
Q54567819 | Differential response of splenic monocytes and DC from cattle to microbial stimulation with Mycobacterium bovis BCG and Babesia bovis merozoites. |
Q36999560 | Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans |
Q37691488 | EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages |
Q44704028 | Effect of L-arginine analogs and a calcium chelator on nitric oxide (NO) production by Leishmania sp. |
Q34931672 | Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans |
Q71781482 | Effect of nitric oxide donors on survival of conidia, germination and growth of Aspergillus fumigatus in vitro |
Q36951075 | Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages |
Q35124444 | Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
Q63247612 | Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages |
Q36972580 | Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice |
Q39784797 | Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B. |
Q44653973 | Enzymes that Counteract Nitrosative Stress Promote Fungal Virulence |
Q41021483 | Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication |
Q41020550 | Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes |
Q36850165 | Genetic regulation of macrophage priming/activation: the Lsh gene story |
Q34532078 | Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent. |
Q36980669 | Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines |
Q36363319 | Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism |
Q33649553 | Human defenses against Cryptococcus neoformans: an update |
Q33672060 | Identification of arginine as a precursor of endothelium-derived relaxing factor |
Q37957849 | Immunological aspects of fungal pathogenesis |
Q64054632 | Immunometabolism of Phagocytes and Relationships to Cardiac Repair |
Q44662507 | Immunostimulatory DNA from Paracoccidioides brasiliensis acts as T-helper 1 promoter in susceptible mice. |
Q34230852 | In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria |
Q35433678 | In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide |
Q35027324 | Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pylori |
Q41624291 | Induction of nitric oxide synthase is a necessary precondition for expression of tumor necrosis factor-independent tumoricidal activity by activated macrophages |
Q39830479 | Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice |
Q43896587 | Infection and nitric oxide |
Q35422948 | Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form |
Q34117500 | Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis |
Q34532614 | Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). |
Q39590479 | Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. |
Q77995140 | Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans |
Q34237322 | Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells |
Q44907215 | Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans |
Q36958434 | Intracellular growth inhibition of Histoplasma capsulatum induced in murine macrophages by recombinant gamma interferon is not due to a limitation of the supply of methionine or cysteine to the fungus |
Q35410685 | Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment |
Q34118196 | Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge |
Q35512116 | Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. |
Q41447238 | Iron regulates nitric oxide synthase activity by controlling nuclear transcription |
Q36968605 | Killing of Plasmodium falciparum in vitro by nitric oxide derivatives |
Q42475424 | L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation |
Q41725075 | L-citrulline production from L-arginine by macrophage nitric oxide synthase. The ureido oxygen derives from dioxygen |
Q34002542 | Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages |
Q39822116 | Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages |
Q36362384 | Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10 |
Q54056915 | Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: comparison between rat alveolar and interstitial lung macrophages. |
Q36935291 | Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection |
Q42091310 | Macrophage activation for intracellular killing as induced by a Ca2+ ionophore. Dependence on l-arginine-derived nitrogen oxidation products |
Q40885442 | Macrophage interactions in toxoplasmosis |
Q36968357 | Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates |
Q34240927 | Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages |
Q36192349 | Microbial strategies to prevent oxygen-dependent killing by phagocytes |
Q35115708 | Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy |
Q33754371 | Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans |
Q68361554 | Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis |
Q24633512 | Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice |
Q33858380 | Nitric oxide and peroxynitrite in the perinatal period. |
Q27485884 | Nitric oxide and virus infection |
Q36684502 | Nitric oxide as an endogenous mutagen for Sendai virus without antiviral activity |
Q34874996 | Nitric oxide in respiratory diseases. |
Q34546031 | Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro |
Q36362030 | Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study |
Q42164304 | Nitric oxide produced in Peyer's patches exhibits antiapoptotic activity contributing to an antimicrobial effect in murine salmonellosis |
Q41856492 | Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review |
Q47915703 | Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol dependent chemiluminescence. |
Q41299658 | Nitric oxide synthesis by rat pleural mesothelial cells: induction by growth factors and lipopolysaccharide |
Q74591765 | Nitric oxide synthesis during acute SIV mac251 infection of macaques |
Q33604156 | Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages |
Q44221658 | Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues |
Q36436856 | Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. |
Q41052100 | Nitric oxide-mediated cytotoxic effects of alveolar macrophages on transformed lung epithelial cells are independent of the beta 2 integrin-mediated intercellular adhesion |
Q40399921 | Nitric oxide. Novel biology with clinical relevance |
Q43832923 | Nitrogen oxide levels in patients after trauma and during sepsis |
Q47829527 | Pathophysiological chemistry of nitric oxide and its oxygenation by-products. |
Q37322024 | Protective role of nitric oxide in ocular toxoplasmosis |
Q39512732 | Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. |
Q35609727 | Regulation of inflammatory responses to Bordetella pertussis by N(G)-monomethyl-L-arginine in mice intranasally infected |
Q72041326 | Release of reactive oxygen and nitrogen intermediates from monocytes of patients with pulmonary tuberculosis |
Q33596326 | Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis |
Q50120579 | Role of Pasteurella multocida, Pasteurella haemolytica and Salmonella typhimurium porins on inducible nitric oxide release by murine macrophages |
Q37982832 | Role of arginine in trauma, sepsis, and immunity |
Q34191797 | Role of free radicals in viral pathogenesis and mutation |
Q39401256 | Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains |
Q39655032 | Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities |
Q36656920 | Role of nitric oxide synthesis in macrophage antimicrobial activity |
Q24683780 | Role of oxidants in microbial pathophysiology |
Q36230297 | Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity |
Q34289451 | STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice |
Q36281328 | STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans |
Q50191058 | Sensitivity of bacteria to NaNO2 and to L-arginine-dependent system in murine macrophages |
Q35762897 | Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calcium-dependent neuronal nitric-oxide synthase |
Q28369007 | Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro |
Q54183886 | Synergy of fluconazole with macrophages for antifungal activity against Candida albicans. |
Q37041650 | Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity |
Q40507021 | The emerging multifaceted roles of nitric oxide |
Q33716138 | The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans |
Q71834571 | The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils |
Q35193841 | The metabolic effects of thermal injury |
Q41600919 | The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta |
Q40373297 | The regulation of pulmonary immunity. |
Q54323502 | The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. |
Q33751411 | Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. |
Q35457307 | Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages |
Q38193589 | Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. |
Q36720631 | Two unique aspects of inducible .N=0 synthase in liver cells and accessory cells: hepatic damage is minimized by hepatocyte .N=0 production and immunoregulation is mediated by macrophage. .N=O production |
Search more.